The NKCA is delivered by the Clinical Effectiveness Unit (CEU) within the Royal College of Surgeons of England.
The overall aim of the NCKA is to improve the quality of care for people with kidney cancer in England and Wales. The NKCA looks at the care, treatment and outcomes for kidney cancer patients treated in NHS hospitals in England and Wales.
The audit’s specific objectives are to look at:
- Increasing the fairness in timely access to evidence-based kidney cancer services across England and Wales
- Increasing the use of kidney tumour biopsy
- Speed up treatment for patients with high-risk kidney cancer
- Reducing over-treatment and under-treatment of kidney cancer patients
- Increasing the use of anticancer therapy in suitable patients without severe side effects